ОСОБЕННОСТИ ПРЕГРАВИДАРНОЙ ПОДГОТОВКИ ПРИ ЭНДОКРИННЫХ ЗАБОЛЕВАНИЯХ. ОБЗОР ЛИТЕРАТУРЫ


Каширина Е.Ж., Маклакова Т.П.

Аннотация


Обзор посвящен особенностям прегравидарной подготовки при эндокринных заболеваниях. Показано, что одним из наиболее сложных вопросов современной акушерско-гинекологической помощи является беременность и роды при экстрагенитальных заболеваниях. Особая роль среди соматической патологии отводится эндокринным патологиям, в особенности ожирению, сахарному диабету и заболеваниям щитовидной железы. Эндокринные патологии зачастую приводят к невынашиванию беременности. Таким образом, перед акушерами встает новая задача – оптимизация прегравидарной подготовки пациенток с эндокринными заболеваниями.

Ключевые слова


прегравидарная подготовка; невынашивание беременности; эндокринные заболевания; ожирение; сахарный диабет

Полный текст:

Full Text HTML Full Text PDF

Литература


Soepnel LM, Norris SA, Mabetha K, Motlhatlhedi M, Nkosi N, Lye S, Draper CE. A qualitative analysis of community health worker perspectives on the implementation of the preconception and pregnancy phases of the Bukhali randomised controlled trial. PLOS Glob Public Health. 2024; 4(3): e0002578. doi: 10.1371/journal.pgph.0002578

Farkas AH, Kibicho J, Ndakuya-Fitzgerald F, Mu Q. Development of the Ready to Care Survey for VA Women's Health Primary Care Provider. J Gen Intern Med. 2024; 39(6): 1010-1014. doi: 10.1007/s11606-023-08467-y

Kostsova LV, Gutikova LV, Zhegzdrin OA. Preconception preparation of women with a history of early pregnancy loss. Reproductive Health. Eastern Europe. 2022; 12(3): 338-347. Russian (Косцова Л.В., Гутикова Л.В., Жегздрин О.А. Прегравидарная подготовка женщин с невынашиванием беременности ранних сроков в анамнезе //Репродуктивное здоровье. Восточная Европа. 2022. Т. 12, № 3. С. 338-347)

Misharina EV, Yarmolinskaya MI, Tiselko AV. The role of pre-pregnancy care for women with pregestational diabetes mellitus for improving maternal and perinatal outcomes. Journal of Obstetrics and Women's Diseases. 2022; 71(3): 87-100. Russian (Мишарина Е.В., Ярмолинская М.И., Тиселько А.В. Роль прегравидарной подготовки в снижении частоты перинатальных осложнений у пациенток с прегестационным сахарным диабетом //Журнал акушерства и женских болезней. 2022. Т. 71, № 3. С. 87-100.) doi: 17816/JOWD101090

Bradfield Z, Leefhelm E, Soh SE, Black KI, Boyle JA, Kuliukas L, et al. The MidPIC study: Midwives' knowledge, perspectives and learning needs regarding preconception and interconception care. PLoS One. 2023; 18(11): e0289910. doi: 10.1371/journal.pone.0289910

Mack N, Crawford TJ, Guise JM, Chen M, Grey TW, Feldblum PJ, et al. Strategies to improve adherence and continuation of shorter-term hormonal methods of contraception. Cochrane Database Syst Rev. 2019; 4(4): CD004317. doi: 10.1002/14651858.CD004317.pub5

Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, et al. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Cochrane Database Syst Rev. 2022; 2(2022): CD014217. doi: 10.1002/14651858.CD014217

Ramanadhan S, Hansen K, Henderson JT, Cohen MA, Paynter R, Edelman A. Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception. Cochrane Database Syst Rev. 2023; 5(5): CD014908. doi: 10.1002/14651858.CD014908.pub3

Lopez LM, Chen M, Mullins Long S, Curtis KM, Helmerhorst FM. Steroidal contraceptives and bone fractures in women: evidence from observational studies. Cochrane Database Syst Rev. 2015; 2015(7): CD009849. doi: 10.1002/14651858.CD009849.pub3

Cohen MA, Edelman A, Paynter R, Henderson JT. Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception. Cochrane Database Syst Rev. 2023; 1(1): CD014908. doi: 10.1002/14651858.CD014908.pub2

Draper CE, Thwala N, Slemming W, Lye SJ, Norris SA. Development, Implementation, and Process Evaluation of Bukhali: An Intervention from Preconception to Early Childhood. Glob Implement Res Appl. 2023; 3(1): 31-43. doi: 10.1007/s43477-023-00073-8

Moloi H, Daniels K, Brooke-Sumner C, Cooper S, Odendaal WA, Thorne M, et al. Healthcare workers' perceptions and experiences of primary healthcare integration: a scoping review of qualitative evidence. Cochrane Database Syst Rev. 2023; 7(7): CD013603. doi: 10.1002/14651858.CD013603.pub3

Lutsiv О, Mah J, Beyene J, McDonald SD. The effects of morbid obesity on maternal and neonatal health outcomes: a systematic review and meta-analyses. Obes Rev. 2015; 16: 531-546. doi: 10.1111/obr.12283

Dolin CD, Kominiarek МА. Pregnancy in women with obesity. Obstet Gynecol Clin North Am. 2018; 45: 217-232. doi: 10.1016/j.ogc.2018.01.005

Pati B, Sendh S, Sahu B, Pani S, Jena N, Bal NC. Recent advancements in pharmacological strategies to modulate energy balance for combating obesity. RSC Med Chem. 2023; 14(8): 1429-1445. doi: 10.1039/d3md00107e

Dedov II, Melnichenko GA, Romantsova TI, Zhuravleva MV. Preliminary analysis of the PRIMAVERA Study: reduxine safety monitoring in patients with alimentary obesity. Endocrine Abstracts. 2015; 37: OC11.5. doi: 10.1530/endoabs.37.OC11.5

Andreeva EN, Grigorian OR, Melnichenko GA. The influence combination of sibutramine/metformin hydrochloride on Anti-Müllerian hormone level in women with metabolic syndrome and polycystic ovary syndrome. Russian Journal of Human Reproduction. 2016; 22(1): 35-39. Russian (Андреева Е.Н., Григорян О.Р., Мельниченко Г.А. Влияние комбинации сибутрамин/метформина гидрохлорид на уровень антимюллерова гормона в терапии синдрома поликистозных яичников у женщин с метаболическим синдромом //Проблемы репродукции. 2016. Т. 22, № 1. С. 35-39.) doi: 10.17116/repro201622135-39

Godala M, Materek-Kuśmierkiewicz I, Moczulski D, Szatko F, Gaszyńska E, Tokarski S, Kowalski J. Estimation of plasma 25(OH)D vitamin level in patients with metabolic syndrome. Pol Merkur Lekarski. 2015; 39(234): 364-367

Zhang Y, Zhang X, Wang F, Zhang W, Wang C, Yu C, et al. The relationship between obesity indices and serum vitamin D levels in Chinese adults from urban settings. Asia Pac J Clin Nutr. 2016; 25(2): 333-339. doi: 10.6133/apjcn.2016.25.2.15

Gutaj P, Zawiejska A, Wender-Ożegowska E, Brązert J. Maternal factors predictive of first‑trimester pregnancy loss in women with pregestational diabetes. Pol Arch Med Wewn. 2013; 123(1-2): 21-28. doi: 10.20452/pamw.1585

O'Brien PE, Hindle A, Brennan L, Skinner S, Burton P, Smith A, et al. Long-Term Outcomes After Bariatric Surgery: a Systematic Review and Meta-analysis of Weight Loss at 10 or More Years for All Bariatric Procedures and a Single-Centre Review of 20-Year Outcomes After Adjustable Gastric Banding. Obes Surg. 2019; 29(1): 3-14. doi: 10.1007/s11695-018-3525-0

Type 2 diabetes mellitus in adults: Clinical guidelines /Ministry of Health of the Russian Federation, 2022. Russian (Сахарный диабет 2­го типа у взрослых: Клинические рекомендации /Минздрав РФ. М., 2022. 251 с.) URL: https://cr.minzdrav.gov.ru/recomend/290_2

Mackin ST, Nelson SM, Wild SH, Colhoun HM, Wood R, Lindsay RS; SDRN Epidemiology Group and Scottish Diabetes Group Pregnancy subgroup. Factors associated with stillbirth in women with diabetes. Diabetologia. 2019; 62(10): 1938-1947. doi: 10.1007/s00125-019-4943-9

Morikawa M, Kato-Hirayama E, Mayama M, Saito Y, Nakagawa K, Umazume T, et al. Glycemic control and fetal growth of women with diabetes mellitus and subsequent hypertensive disorders of pregnancy. PLoS One. 2020; 15(3): e0230488. doi: 10.1371/journal.pone.0230488

Algorithms for specialized medical care for patients with diabetes mellitus: Clinical recommendations. Issue 71 /ed. II Dedova, MV Shestakova. Diabetes mellitus. 2015; 18: 1-112. Russian (Алгоритмы специализированной медицинской помощи больным сахарным диабетом: Клинические рекомендации. Выпуск 7­1 /под ред. И.И Дедова, М.В. Шестаковой //Сахарный диабет. 2015. № 18. С. 1-112)

American Diabetes Association. 14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020; 43(Suppl 1): S183-S192. doi: 10.2337/dc20-S014

Ekpebegh CO, Coetzee EJ, van der Merwe L, Levitt NS. A 10-year retrospective analysis of pregnancy outcome in pregestational Type 2 diabetes: comparison of insulin and oral glucose-lowering agents. Diabet Med. 2007; 24(3): 253-258. doi: 10.1111/j.1464-5491.2007.02053.x

National Collaborating Centre for Women's and Children's Health (UK). Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period. London: National Institute for Health and Care Excellence (UK); 2015

Mahmud M, Mazza D. Preconception care of women with diabetes: a review of current guideline recommendations. BMC Womens Health. 2010; 10: 5. doi: 10.1186/1472-6874-10-5

Defeudis G, Mazzilli R, Benvenuto D, Ciccozzi M, Di Tommaso AM, Faggiano A, et al. Women with type 1 diabetes gain more weight during pregnancy compared to age-matched healthy women despite a healthier diet: a prospective case-control observational study. Hormones (Athens). 2023; 22(3): 389-394. doi: 10.1007/s42000-023-00454-6

Petersen JM, Parker SE, Benedum CM, Mitchell AA, Tinker SC, Werler MM. Periconceptional folic acid and risk for neural tube defects among higher risk pregnancies. Birth Defects Res. 2019; 111(19): 1501-1512. doi: 10.1002/bdr2.1579

Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017; 27(3): 315-389. doi: 10.1089/thy.2016.0457

Hypothyroidism: Clinical guidelines / Ministry of Health of the Russian Federation. M., 2021. Russian (Гипотиреоз: Клинические рекомендации /Минздрав РФ. М., 2021. 34 с.)

Wiersinga WM, Poppe KG, Effraimidis G. Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis. Lancet Diabetes Endocrinol. 2023; 11(4): 282-298. doi: 10.1016/S2213-8587(23)00005-0

Kalra B, Sawhney K, Kalra S. Management of thyroid disorders in pregnancy: Recommendations made simple. J Pak Med Assoc. 2017; 67(9): 1452-1455

Lee SY, Pearce EN. Assessment and treatment of thyroid disorders in pregnancy and the postpartum period. Nat Rev Endocrinol. 2022; 18(3): 158-171. doi: 10.1038/s41574-021-00604-z

Endocrinology: Russian clinical guidelines /ed. I.I. Dedova, G.A. Melnichenko., 2016. Russian (Эндокринология: Российские клинические рекомендации /под ред. И.И. Дедова, Г.А. Мельниченко. М.: ГЭОТАР­Медиа, 2016. 598 с.)

Maraka S, Ospina NM, O'Keeffe DT, De Ycaza AEE, Gionfriddo MR, Erwin PJ, et al. Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis. Thyroid. 2016; 26(4): 580-90. doi: 10.1089/thy.2015.0418

Early pregnancy. From prenatal preparation to healthy gestation /ed. VE Radzinsky, AA Orazmuradova. M., 2018. 800 p. Russian (Беременность ранних сроков. От прегравидарной подготовки к здоровой гестации /под ред. В.Е. Радзинского, А.А. Оразмурадова. М., 2018. 800 с.)

Fetene DM, Betts KS, Alati R. MECHANISMS IN ENDOCRINOLOGY: Maternal thyroid dysfunction during pregnancy and behavioural and psychiatric disorders of children: a systematic review. Eur J Endocrinol. 2017; 177(5): R261-R273. doi: 10.1530/EJE-16-0860

Sullivan SD, Downs E, Popoveniuc G, Zeymo A, Jonklaas J, Burman KD. Randomized Trial Comparing Two Algorithms for Levothyroxine Dose Adjustment in Pregnant Women With Primary Hypothyroidism. J Clin Endocrinol Metab. 2017; 102(9): 3499-3507. doi: 10.1210/jc.2017-01086

Women's consultation: Guide /ed. VE Radzinsky. M.: GEOTAR-Media, 2021. 576 p. Russian (Женская консультация: Руководство /под ред. В.Е. Радзинского. М.: ГЭОТАР­Медиа, 2021. 576 с.)

Andersen SL, Olsen J, Laurberg P. Antithyroid Drug Side Effects in the Population and in Pregnancy. J Clin Endocrinol Metab. 2016; 101(4): 1606-1614. doi: 10.1210/jc.2015-4274

Andersen SL, Olsen J, Wu CS, Laurberg P. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study. J Clin Endocrinol Metab. 2013; 98(11): 4373-4381. doi: 10.1210/jc.2013-2831

Essays on endocrine gynecology /ed. VE Radzinsky. M., 2023. 672 p. Russian (Очерки эндокринной гинекологии /под ред. В.Е. Радзинского. М., 2023. 672 с.)

Clinical pharmacology. Obstetrics. Gynecology. Infertile marriage /ed. VE Radzinsky, RN Alyautdina. M.: GEOTAR-Media, 2016. 672 p. Russian (Клиническая фармакология. Акушерство. Гинекология. Бесплодный брак /под ред. В.Е. Радзинского, Р.Н. Аляутдина. М.: ГЭОТАР­Медиа, 2016. 672 с.)

Hyperprolactinemia: Clinical guidelines /Ministry of Health of the Russian Federation. M., 2016. 30 p. Russian (Гиперпролактинемия: Клинические рекомендации /Минздрав РФ. М., 2016. 30 с.)

Sharma LK, Sharma N, Gadpayle AK, Dutta D. Prevalence and predictors of hyperprolactinemia in subclinical hypothyroidism. Eur J Intern Med. 2016; 35: 106-110. doi: 10.1016/j.ejim.2016.07.012

Tykhonova T, Barabash N, Kanishcheva O. Current and Perspective Approaches to the Treatment of Prolactinomas. Acta Med Litu. 2023; 30(2): 96-107. doi: 10.15388/Amed.2023.30.2.1

Hu Y, Ding Y, Yang M, Xiang Z. Serum prolactin levels across pregnancy and the establishment of reference intervals. Clin Chem Lab Med. 2018; 56(5): 838-842. doi: 10.1515/cclm-2017-0644

Prencipe N, Bona C, Cuboni D, Berton AM, Bioletto F, Varaldo E, et al. Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center. Pituitary. 2024 Mar 18. doi: 10.1007/s11102-024-01384-1

Soto-Pedre E, Newey PJ, Bevan JS, Greig N, Leese GP. The epidemiology of hyperprolactinaemia over 20 years in the Tayside region of Scotland: the Prolactin Epidemiology, Audit and Research Study (PROLEARS). Clin Endocrinol (Oxf). 2017; 86(1): 60-67. doi: 10.1111/cen.13156


Статистика просмотров

Загрузка метрик ...

Ссылки

  • На текущий момент ссылки отсутствуют.